pylori -induced carcinogenesis of gastric mucosal may be ameliorated in rats by raising their GSH levels, which may also prevent oxidative stress damage (108)
Subsequently, GLP-1s gained FDA approval for weight loss in 2014 (liraglutide: Saxenda/Victoza), 2021 (semaglutide: Wegovy/Ozempic/Rybelsus), and 2023 (tirzepatide: Zepbound/Mounjaro)
Following the global attention on weight loss drugs like Ozempic and Wegovy, rumors of pilot clinical trials and safety studies involving dogs and cats began to circulate
Dangerously low blood sugar levels
Adipose tissue reduction decreases free fatty acid release into circulation, potentially reducing hepatic triglyceride synthesis and very-low-density lipoprotein (VLDL) production
Wegovy mimics GLP-1, a hormone that regulates appetite and food intake, and is covered by many commercial insurance plans